{"DataElement":{"publicId":"5917044","version":"1","preferredName":"Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index Risk Assessment Category","preferredDefinition":"A response used to estimate a patient's risk of mantle cell lymphoma progression or relapse and overall survival following therapy using a scoring system. It uses the criteria of patient's age, ECOG performance status, serum LDH activity, WBC count and Ki-67 index to classify patients into low risk, medium risk or high risk groups. The MIPIb score is calculated using the formula: [0.03535 x age (years)] + 0.6978 (if ECOG > 1) + [1.367 x log10(LDH/ULN)] + [0.9393 x log10(WBC count)] + [0.02142 x Ki-67 (%)]. A score < 5.7 indicates low risk disease, 5.7 - 6.5 indicates intermediate risk, and 6.5 or greater high risk.","longName":"5836958v1.0:5917037v1.0","context":"ECOG-ACRIN","contextVersion":"1","DataElementConcept":{"publicId":"5836958","version":"1","preferredName":"Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index Risk Assessment","preferredDefinition":"A scoring system designed to classify a patient's risk of mantle cell lymphoma progression or relapse and overall survival following therapy. It uses the criteria of patient's age, ECOG performance status, serum LDH activity, WBC count and Ki-67 index to classify patients into low risk, medium risk or high risk groups. The MIPIb score is calculated using the formula: [0.03535 x age (years)] + 0.6978 (if ECOG > 1) + [1.367 x log10(LDH/ULN)] + [0.9393 x log10(WBC count)] + [0.02142 x Ki-67 (%)]. A score < 5.7 indicates low risk disease, 5.7 - 6.5 indicates intermediate risk, and 6.5 or greater high risk._An estimated probability that one or more adverse event(s) will occur as a result of exposure to an actual or potential hazardous situation or chemical.","longName":"5917043v1.0:2233190v1.0","context":"ECOG-ACRIN","contextVersion":"1","ObjectClass":{"publicId":"5917043","version":"1","preferredName":"Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","preferredDefinition":"A scoring system designed to classify a patient's risk of mantle cell lymphoma progression or relapse and overall survival following therapy. It uses the criteria of patient's age, ECOG performance status, serum LDH activity, WBC count and Ki-67 index to classify patients into low risk, medium risk or high risk groups. The MIPIb score is calculated using the formula: [0.03535 x age (years)] + 0.6978 (if ECOG > 1) + [1.367 x log10(LDH/ULN)] + [0.9393 x log10(WBC count)] + [0.02142 x Ki-67 (%)]. A score < 5.7 indicates low risk disease, 5.7 - 6.5 indicates intermediate risk, and 6.5 or greater high risk.","longName":"C134315","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","conceptCode":"C134315","definition":"A scoring system designed to classify a patient's risk of mantle cell lymphoma progression or relapse and overall survival following therapy. It uses the criteria of patient's age, ECOG performance status, serum LDH activity, WBC count and Ki-67 index to classify patients into low risk, medium risk or high risk groups. The MIPIb score is calculated using the formula: [0.03535 x age (years)] + 0.6978 (if ECOG > 1) + [1.367 x log10(LDH/ULN)] + [0.9393 x log10(WBC count)] + [0.02142 x Ki-67 (%)]. A score < 5.7 indicates low risk disease, 5.7 - 6.5 indicates intermediate risk, and 6.5 or greater high risk.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55C9A2F6-2BC2-3E47-E053-F662850A4F8B","latestVersionIndicator":"Yes","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"ONEDATA","dateModified":"2017-08-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2233190","version":"1","preferredName":"Risk Assessment","preferredDefinition":"The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences.","longName":"C15367","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Health Risk Assessment","conceptCode":"C15367","definition":"An estimated probability that one or more adverse event(s) will occur as a result of exposure to an actual or potential hazardous situation or chemical.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F92F8E39-682F-375C-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-10","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-06-10","modifiedBy":"ONEDATA","dateModified":"2005-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"50220BD3-1488-6104-E053-F662850A53FA","latestVersionIndicator":"Yes","beginDate":"2017-05-22","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-05-22","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeDescription":"Created for EA4151, 5/22/17 JG","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5917037","version":"1","preferredName":"Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index Risk Assessment Category","preferredDefinition":"A grouping of items based on some commonality or by user defined characteristics.","longName":"5917037v1.0","context":"ECOG-ACRIN","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":null,"minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Low/Intermediate","valueDescription":"Low-Intermediate Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","ValueMeaning":{"publicId":"5917040","version":"1","preferredName":"Low-Intermediate Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","longName":"5917040","preferredDefinition":"Low risk MIPI score (0-3) and Ki-67 greater than or equal to 30% or Intermediate risk MIPI score (4-5) and Ki-67 less than 30%. MIPI-c low-intermediate risk equals a MIPI-c score of 1.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low-Intermediate Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","conceptCode":"C137808","definition":"Low risk MIPI score (0-3) and Ki-67 greater than or equal to 30% or Intermediate risk MIPI score (4-5) and Ki-67 less than 30%. MIPI-c low-intermediate risk equals a MIPI-c score of 1.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55C9A2F6-2B70-3E47-E053-F662850A4F8B","latestVersionIndicator":"Yes","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"55C9A2F6-2B8B-3E47-E053-F662850A4F8B","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"ONEDATA","dateModified":"2017-08-02","deletedIndicator":"No"},{"value":"Low","valueDescription":"Low Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","ValueMeaning":{"publicId":"5917041","version":"1","preferredName":"Low Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","longName":"5917041","preferredDefinition":"Low risk MIPI score (0-3) and Ki-67 less than 30%. Low risk MIPI-c equals a MIPI-c score of 0.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","conceptCode":"C137807","definition":"Low risk MIPI score (0-3) and Ki-67 less than 30%. Low risk MIPI-c equals a MIPI-c score of 0.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55C9A2F6-2B97-3E47-E053-F662850A4F8B","latestVersionIndicator":"Yes","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"55C9A2F6-2BB2-3E47-E053-F662850A4F8B","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"ONEDATA","dateModified":"2017-08-02","deletedIndicator":"No"},{"value":"High/Intermediate and High","valueDescription":"High-Intermediate Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","ValueMeaning":{"publicId":"5917039","version":"1","preferredName":"High-Intermediate Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","longName":"5917039","preferredDefinition":"Intermediate risk MIPI score (4-5) and Ki-67 greater than or equal to 30% or High risk MIPI score (6-11) and Ki-67 less than 30%. A MIPI-c high-intermediate risk equals a MIPI-c score of 2.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High-Intermediate Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","conceptCode":"C137809","definition":"Intermediate risk MIPI score (4-5) and Ki-67 greater than or equal to 30% or High risk MIPI score (6-11) and Ki-67 less than 30%. A MIPI-c high-intermediate risk equals a MIPI-c score of 2.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55C9A2F6-2B49-3E47-E053-F662850A4F8B","latestVersionIndicator":"Yes","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"55CA5632-6FD4-2AB6-E053-F662850A7686","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"ONEDATA","dateModified":"2017-08-02","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2577194","version":"1","preferredName":"Indeterminate","longName":"2577194","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-FA97-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"COOPERM","dateModified":"2008-09-15","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"55CA6647-70D1-358E-E053-F662850A96AE","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"ONEDATA","dateModified":"2017-08-02","deletedIndicator":"No"},{"value":"High","valueDescription":"High Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","ValueMeaning":{"publicId":"5917038","version":"1","preferredName":"High Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","longName":"5917038","preferredDefinition":"High risk MIPI score (6-11) and Ki-67 greater than or equal to 30%. A MIPI-c high risk equals a MIPI-c score of 3.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Risk Mantle Cell Lymphoma International Prognostic Index Combined Biologic Index","conceptCode":"C137810","definition":"High risk MIPI score (6-11) and Ki-67 greater than or equal to 30%. A MIPI-c high risk equals a MIPI-c score of 3.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"55C9A2F6-2B22-3E47-E053-F662850A4F8B","latestVersionIndicator":"Yes","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"55CA6647-70E5-358E-E053-F662850A96AE","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"ONEDATA","dateModified":"2017-08-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2433877","version":"1","preferredName":"Category","preferredDefinition":"Category; used informally to mean a class of things.","longName":"C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"062E16DD-4D2F-16F1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-28","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-28","modifiedBy":"ONEDATA","dateModified":"2005-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55C9A2F6-2B09-3E47-E053-F662850A4F8B","latestVersionIndicator":"Yes","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeDescription":"Created for EA4151, JG 8/2/2017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3314482","version":"1","longName":"Type of Category","context":"ECOG-ACRIN","ClassificationSchemeItems":[{"publicId":"10000277","version":"1","longName":"Eligibility","context":"ECOG-ACRIN"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"MIPI-c score","type":"Preferred Question Text","description":"MIPI-c score","url":null,"context":"ECOG-ACRIN"}],"origin":"ECOG CRF:Eastern Cooperative Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"55C7DFA3-4379-1E82-E053-F662850AFDCF","latestVersionIndicator":"Yes","beginDate":"2017-08-02","endDate":null,"createdBy":"GARRIDOJ","dateCreated":"2017-08-02","modifiedBy":"GARRIDOJ","dateModified":"2017-10-02","changeDescription":"Created for EA4151, JG 8/2/2017","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}